in vitro some let viruses through,56"l and electron microscopy has shown pores. 6 Spermicides are usually enclosed in media to slow the progression of sperms and occlude the external uterine ostium. Spermicideimpregnated sponges combine the actions of a physical barrier that blocks the cervix with a material that absorbs ejaculate, and a spermicide.12 Spermicides are not a single class of chemicals. For instance, nonoxynol-9 (N-9) is classified as a surfactant,13 while benzalkonium chloride is a disinfectant'3 and phenylmercuric acetate is an organic mercurial compound (aryl mercurial). '4 In vitro benzalkonium chloride has a direct inhibitory effect on HIV'5 and N-9 inhibits the growth of several infective agents, such as Treponema pallidum,16 Neisseria gonorrhoeae,16
Chlamydia trachomatis,4 1718 HSV 419 and CMV20 but not bovine papilloma virus (BPV-1) and BK Virus (BKV).20 As BPV-1 is closely related to HPV, it is reasonable to assume that N-9 does not inactivate the latter either.
At the concentrations usually used for spermicidal effect N-9 is highly effective in vitro against HIV and HIV-infected cultures of human lymphocytes21-23 and foams and gels containing N-9 prevented genital transmission of simian immunodeficiency virus (SIV) in rhesus macaques. 24 Doubts remain about the amount of spermicide in commercially available condoms25 and whether the concentration after the rupture of standard devices during sexual intercourse is sufficient to kill pathogens in vivo. 3 25 It has also been suggested that the use of N-9 may disrupt the vaginal epithelium,2627 making infection easier. Chlorexidine is now under study as a spermicide: it is less irritant on mucosal cells than N-9. 28 Evidence is available about mineral-based lubricants being erroneously used with latex condoms. One study also presented the results for t90% Confidence Interval in brackets. *BMC with spermiicide. Non-gonococcal urethritis and cervical infections These diseases are considered in Table 2 . Two studies analysed the role of condom on female risk of non-gonococcal urethritis: no protection emerged.35 41 The estimated OR were 0-8 (non-significant) and 0.3 (95% CI 0-2-0.7) in the two studies analysing the effect of condoms on the risk of non-gonococcal urethritis in males.3845 A protective effect of the diaphragm on non-gonococcal infections in women emerged in two studies conducted in the USA.3546 Likewise OR were 0-1 and 0'2 (statistically significant) in the two studies that analysed the role of BMC altogether.4748 These findings were consistent considering separately the available data for chlamydiae and Ureaplasma urealithicum.
HIV
We reviewed 21 tSponge. Some of the inconsistencies may arise from heterogeneity in study populations outcomes and frequency of BMC use. For example, the only subgroup showing no protection for condoms against gonorrhoea was related to repeated episodes in a study that shows protection for single episodes. 37 It is likely that the lack of protection is restricted to subjects who did not use condoms correctly. Whenever results are presented for "correct" vs "incorrect" or for "always" vs "not always" BMC users, good compliers appear more protected than poor compliers.'83949545662
Even if used properly, condoms may not protect against organisms transmitted by external or -indirect genital contact. Further, the protection may differ for different brands of condoms. For example, laboratory experiments conducted in Italy by an independent consumer association indicated that only half of the brands of ten thousand condoms purchased in shops passed tests conducted according to International Standard Organisation (ISO) methods, and only one fourth of brands had a "good" evaluation. 93 Few studies have compared the efficacy of condoms and diaphragms in protection against STD. No randomised trial was found. However, the diaphragm appears to have a protective effect against gonorrhoea and nongonococcal urethritis and cervical infections similar to that of condoms.
The irritative effect of N-9 on the vaginal mucosa may cause ulcers.70 Both clinical trials documenting a role of N-9 in genital ulceration or symptomatic irritation7072 investigated prostitutes, and may therefore not be representative of the general population. Niruthisard et al 94 found that cumulative doses of N-9 caused a high rate of irritation and epithelial lesions of the vagina, but only rare and mild adverse reactions were reported from RCT based on the general population7' . Quite possibly prostitutes experienced a dose-dependent adverse effect which is not applicable to the whole population.
Another open issue is the potential interaction between BMC and spermicides both in terms of roles of separate or combined utilisation, and of separate or combined impact on the subsequent risk of STD.
In conclusion, many studies deal with the effect of BMC on the risk of gonorrhoea and HIV transmission, but results are still scanty for other infections. Few data are available to analyse the comparative effect of condom and diaphragm, and the role of spermicides. In particular, N-9 seems to have different effects on different pathogens.
A final consideration as regards the public health implications of the studies reviewed. A consistent and strong protection may well be acceptable for treatable diseases and rare exposures, but a similar protection is clearly not satisfactory for frequent exposures and, particularly, serious or severe diseases. These data, therefore, offer some guidelines for risk assessment, but should be applied with due caution for any individual choice.
